NEW YORK--(BUSINESS WIRE)--Genomic Expression, Inc., a leader in the development of innovative sequencing technology for personalized medicine, today announced the successful closing of financing from the Seattle Women’s Impact Fund and the appointment of its co-founder, Kim Tennican, to Genomic Expression’s board of directors. Ms.Tennican commented, “We are thrilled to be supporting Genomic Expression as they pursue their mission to save lives and make health care more effective. Their genomic
| < Prev | Next > |
|---|
